We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Radian Group
RDN
$5.16B
| $5.24M | 0.01% |
291,779
+11,163
| +4% | +$207K |
|
|
AXE
977
DELISTED
Anixter International Inc
AXE
| $5.23M | 0.01% |
65,948
+16,536
| +33% | +$1.35M |
|
|
TSRO
978
DELISTED
TESARO, Inc.
TSRO
| $5.22M | 0.01% |
33,954
+2,337
| +7% | +$380K |
|
|
AKRX
979
DELISTED
Akorn Inc
AKRX
| $5.22M | 0.01% |
216,613
+6,910
| +3% | +$150K |
|
980
Alcoa
AA
$11.9B
| $5.2M | 0.01% |
151,197
+10,385
| +7% | +$363K |
|
981
GATX Corp
GATX
$6.45B
| $5.19M | 0.01% |
85,120
+2,558
| +3% | +$151K |
|
982
Exelixis
EXEL
$14.1B
| $5.18M | 0.01% |
239,108
+13,397
| +6% | +$272K |
|
983
Brinker International
EAT
$9B
| $5.16M | 0.01% |
117,470
+8,256
| +8% | +$366K |
|
984
Steris
STE
$22.5B
| $5.16M | 0.01% |
74,243
+292
| +0.4% | +$20.2K |
|
|
MZTI
985
The Marzetti Company
MZTI
$2.95B
| $5.16M | 0.01% |
40,021
+1,252
| +3% | +$168K |
|
986
Diamondrock Hospitality Co
DRH
$2.64B
| $5.15M | 0.01% |
462,195
+116,147
| +34% | +$1.3M |
|
987
Sunstone Hotel Investors
SHO
$2.18B
| $5.13M | 0.01% |
334,744
+19,725
| +6% | +$294K |
|
988
Applied Industrial Technologies
AIT
$12.6B
| $5.13M | 0.01% |
82,889
+20,660
| +33% | +$1.27M |
|
|
EFII
989
DELISTED
Electronics for Imaging
EFII
| $5.12M | 0.01% |
104,929
+25,400
| +32% | +$1.17M |
|
|
EQC
990
DELISTED
Equity Commonwealth
EQC
| $5.12M | 0.01% |
163,896
+6,397
| +4% | +$198K |
|
|
WAGE
991
DELISTED
WageWorks, Inc.
WAGE
| $5.12M | 0.01% |
70,771
+20,817
| +42% | +$1.54M |
|
992
LCI Industries
LCII
$2.5B
| $5.11M | 0.01% |
51,241
+13,778
| +37% | +$1.48M |
|
|
RAD
993
DELISTED
Rite Aid Corporation
RAD
| $5.11M | 0.01% |
60,069
+4
| +0% | +$482 |
|
|
ATHN
994
DELISTED
Athenahealth, Inc.
ATHN
| $5.11M | 0.01% |
45,314
+1,754
| +4% | +$204K |
|
995
Chord Energy
CHRD
$7.78B
| $5.1M | 0.01% |
357,760
+34,592
| +11% | +$487K |
|
996
Papa John's
PZZA
$995M
| $5.07M | 0.01% |
63,356
+1,542
| +2% | +$125K |
|
997
FirstCash
FCFS
$8.76B
| $5.07M | 0.01% |
103,067
+24,149
| +31% | +$1.07M |
|
998
Herbalife
HLF
$1.29B
| $5.06M | 0.01% |
174,194
+6,242
| +4% | +$174K |
|
999
Wolfspeed
WOLF
$1.24B
| $5.05M | 0.01% |
189,043
+5,142
| +3% | +$140K |
|
1000
CVB Financial
CVBF
$4B
| $5M | 0.01% |
226,171
+54,715
| +32% | +$1.25M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.